CN117481270A - Blood replenishing tablet for pets and preparation method thereof - Google Patents

Abstract

The invention relates to the technical field of blood replenishing tablets, and discloses a blood replenishing tablet for pets and a preparation method thereof, and in order to achieve the purposes, the blood replenishing tablet is prepared by mixing an iron glycine complex, zinc glycine, lactoferrin, igG immunoglobulin (10% bovine coloctrum) and mannooligosaccharide; preferably, the content of the iron glycine complex in each gram is more than or equal to twenty-five milligrams and less than thirty milligrams, and the iron glycine complex is prepared by taking glycine and inorganic ferric salt as main raw materials through a complexation reaction; preferably, the utilization of the glycine iron complex, zinc glycinate, lactoferrin, igG immunoglobulin (10% bovine colostrum) and mannooligosaccharide in the scheme can be suitable for nutrition supplementation of iron-deficiency anemia of cats and dogs; blood replenishing during postoperative and traumatic recovery period, ischemic nutrition supplementing during senile gestation period, and nutritional supplementation of anaemia diseases caused by infection; regulate immunity, promote the improvement of autoimmune function of pets (cats and dogs) with poor health.

Description

A blood-tonifying tablet for pets and its preparation method

Technical field

The present application relates to the technical field of blood-tonifying tablets, and in particular to a blood-tonifying tablet for pets and a preparation method thereof.

Background technique

In recent years, the average annual growth rate of my country's pet economy has exceeded 30%. With the expansion of my country's pet market and the strengthening of pet health awareness, more and more types of pet products have entered the market in the form of production, sales, and services. Pets are a branch of animal husbandry, but pet breeding is different from animal husbandry. People regard pets more as "companions" and focus on their health and nutrition. Nowadays, the staple food of pets is mainly based on meat, and the diet structure is single. Pets do not need hunting exercise to eat. Lack of exercise can easily lead to unbalanced nutrition and poor physical fitness.

However, in practical applications, most existing pets are prone to anemia due to illness or injury. Due to the lack of exercise in current pets, their own recovery ability and immunity are relatively low. Without external auxiliary treatment, it is very easy to cause deterioration or even Death occurs from organ failure.

Therefore, those skilled in the art provide a blood-tonifying tablet for pets and a preparation method thereof to solve the problems raised in the above background art.

Contents of the invention

In order to solve the problem mentioned in the above background technology that most pets are prone to anemia due to illness or injury. Due to the lack of exercise of current pets, their own recovery ability and immunity are relatively low. Without external auxiliary treatment, it is very easy to cause deterioration and even organ damage. To solve the problem of death due to failure, this application provides a blood supplement tablet for pets and a preparation method thereof.

A blood-tonifying tablet for pets and its preparation method provided by this application adopt the following technical solution: In order to achieve the above purpose, the present invention is composed of iron glycinate complex, zinc glycinate, lactoferrin, IgG immunoglobulin (10% It is a mixture of bovine colostrum) and mannan oligosaccharides.

Preferably, the content of the glycine iron complex per gram is greater than or equal to 25 mg and less than 30 mg. The glycine iron complex uses glycine and inorganic iron salts as main raw materials and is produced through a complexation reaction. have to.

Preferably, the content of zinc glycinate per gram is greater than or equal to fifteen milligrams, and the zinc glycinate is mainly used as a pharmaceutical excipient and a zinc nutritional fortifier.

Preferably, the content of lactoferrin per gram is greater than or equal to five milligrams. Lactoferrin is a core immune function protein that can compete with pathogenic microorganisms for iron sources and resist the invasion of pathogenic microorganisms, thereby protecting the immune system from damage.

Preferably, the immunoglobulin is selected from IgG, and the content of the immunoglobulin per gram is greater than or equal to ten milligrams.

Preferably, the immunoglobulin contains 10% bovine colostrum.

Preferably, the immunoglobulin IgG is operated using a one-way immunodiffusion method and an immunoturbidimetric method.

Preferably, the content of the mannooligosaccharide is greater than or equal to 25 mg per gram. The mannooligosaccharide is a new type of antigenic active substance extracted from the yeast culture cell wall, which can effectively protect the intestinal tract and improve immunity. .

The above-mentioned preparation method of blood supplement tablets for pets includes the following steps:

S1: Finely grind the iron glycinate complex, zinc glycinate, and mannan oligosaccharide, and pass the ground powder through a 120-mesh sieve respectively.

S2: Mix the iron glycinate complex, zinc glycinate, and mannan oligosaccharide together according to the proportion, then drip in a certain proportion of lactoferrin and IgG immunoglobulin to fully fuse.

S3: Let it stand for thirty minutes in an environment of 0℃-5℃.

S4: Pressed and molded, each piece has a mass of 0.6 grams.

To sum up, this application includes the following beneficial technical effects:

1. In this case, the utilization of iron glycinate complex, zinc glycinate, lactoferrin, IgG immunoglobulin (10% bovine colostrum), and mannan oligosaccharide can be applied to the nutritional supplement of cats and dogs with iron deficiency anemia; postoperative It can replenish blood during the recovery period of trauma, supplement ischemic nutrition during the gestation period of the elderly, and supplement nutrition for anemia caused by infection. It can regulate immune function and promote the improvement of the autoimmune function of pets (cats and dogs) in poor health.

Detailed ways

The technical solution of the present invention will be clearly and completely described below. Obviously, the described embodiments are part of the embodiments of the present invention, rather than all the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by those of ordinary skill in the art without creative efforts fall within the scope of protection of the present invention.

In the description of the present invention, the terms "first", "second" and "third" are used for descriptive purposes only and shall not be understood as indicating or implying relative importance. In the description of the present invention, it should be noted that, unless otherwise clearly stated and limited, the terms "installation", "connection" and "connection" should be understood in a broad sense. For example, it can be a fixed connection or a detachable connection. Connection, or integral connection; it can be a mechanical connection or an electrical connection; it can be a direct connection or an indirect connection through an intermediate medium; it can be an internal connection between two components. For those of ordinary skill in the art, the specific meanings of the above terms in the present invention can be understood on a case-by-case basis. In addition, the technical features involved in different embodiments of the present invention described below can be combined with each other as long as they do not conflict with each other.

The embodiments of this application disclose a blood-tonifying tablet for pets and a preparation method thereof. In order to achieve the above purpose, the present invention is composed of iron glycinate complex, zinc glycinate, lactoferrin, and IgG immunoglobulin (10% bovine colostrum). , mannooligosaccharides are mixed.

In this application, the content of the glycine iron complex per gram is greater than or equal to 25 mg and less than 30 mg. The glycine iron complex is prepared through a complexation reaction using glycine and inorganic iron salts as the main raw materials.

In this application, the content of zinc glycinate per gram is greater than or equal to fifteen milligrams. Zinc glycinate is mainly used as a pharmaceutical excipient and a zinc nutritional fortifier.

In this application, the content of lactoferrin per gram is greater than or equal to five milligrams. Lactoferrin is a core immune function protein that can compete with pathogenic microorganisms for iron sources, resist the invasion of pathogenic microorganisms, and thereby protect the immune system from damage.

In this application, IgG is selected as the immunoglobulin, and the immunoglobulin content per gram is greater than or equal to ten milligrams.

In this application, the immunoglobulin contains 10% bovine colostrum.

In this application, immunoglobulin IgG is operated using the one-way immunodiffusion method and the immunoturbidimetric method.

In this application, the content of mannooligosaccharide per gram is greater than or equal to 25 mg. Mannooligosaccharide is a new type of antigenic active substance extracted from the yeast culture cell wall, which can effectively protect the intestinal tract and improve immunity.

The above-mentioned preparation method of blood supplement tablets for pets includes the following steps:

S1: Finely grind the iron glycinate complex, zinc glycinate, and mannan oligosaccharide, and pass the ground powder through a 120-mesh sieve respectively.

S2: Mix the iron glycinate complex, zinc glycinate, and mannan oligosaccharide together according to the proportion, then drip in a certain proportion of lactoferrin and IgG immunoglobulin to fully fuse.

S3: Let it stand for thirty minutes in an environment of 0℃-5℃.

S4: Press molding, the mass of each piece is 0.6 grams;

Finally: the above are only preferred embodiments of the present invention and are not intended to limit the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principles of the present invention shall be included in this present invention. within the scope of protection of the invention.

Claims (10)

1. A blood-tonifying tablet for pets, characterized in that: in order to achieve the above purpose, the present invention is composed of iron glycinate complex, zinc glycinate, lactoferrin, IgG immunoglobulin (10% bovine colostrum), mannan oligosaccharide Mixed with sugar. 2. A blood-tonifying tablet for pets according to claim 1, characterized in that: the content of the iron glycinate complex per gram is greater than or equal to 25 mg and less than 30 mg, and the iron glycinate complex is The complex uses glycine and inorganic iron salt as main raw materials and is produced through complexation reaction. 3. A blood-tonifying tablet for pets according to claim 1, characterized in that: the content of the zinc glycinate per gram is greater than or equal to fifteen milligrams, and the zinc glycinate is mainly used as a pharmaceutical excipient and is zinc Nutrition supplements. 4. A blood-tonifying tablet for pets according to claim 1, characterized in that: the content of lactoferrin per gram is greater than or equal to five milligrams. Lactoferrin is a core immune function protein that can interact with pathogens. Microorganisms compete for iron sources and resist pathogenic microorganisms, thus protecting the immune system from damage. 5. A blood-tonifying tablet for pets according to claim 1, characterized in that: the immunoglobulin is selected from IgG, and the content of the immunoglobulin per gram is greater than or equal to ten milligrams. 6. A blood-tonifying tablet for pets according to claim 1, characterized in that: the immunoglobulin contains 10% bovine colostrum. 7. A blood-tonifying tablet for pets according to claim 5, characterized in that: the immunoglobulin IgG is operated by a one-way immunodiffusion method and an immunoturbidimetric method. 8. A blood-tonifying tablet for pets according to claim 1, characterized in that: the content of the mannooligosaccharide per gram is greater than or equal to 25 mg, and the mannooligosaccharide is obtained from yeast cultured cell walls. A new class of extracted antigenic active substances can effectively protect the intestinal tract and improve immunity. 9. The preparation method of blood-tonifying tablets for pets according to claims 1-8, characterized in that it includes the following steps: S1: Finely grind the iron glycinate complex, zinc glycinate, and mannan oligosaccharide, and pass the ground powder through a 120-mesh sieve respectively. S2: Mix the iron glycinate complex, zinc glycinate, and mannan oligosaccharide together according to the proportion, then drip in a certain proportion of lactoferrin and IgG immunoglobulin to fully fuse. S3: Let it stand for thirty minutes in an environment of 0℃-5℃. S4: Pressed and molded, each piece has a mass of 0.6 grams. 10. The blood-tonifying tablet for pets according to any one of claims 1 to 8 is applied to pets (cats, dogs).